If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
53.50    -1.50 (-2.73%)
Bid:
53.00
Ask:
54.00
Spread: 1.00 (1.887%)
Market Cap: £102.64m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Market update

11 Apr 2016 07:00

RNS Number : 7163U
Iofina PLC
11 April 2016
 

 

11 April 2016

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Q1 MARKET UPDATE

124.6 metric tonnes of iodine produced from five IOsorb® plants

Production target of 250-270 metric tonnes of iodine in H1 2016

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, today provides an update to the market regarding iodine production in the first quarter of 2016.

 

Iofina produced a total of 124.6 metric tonnes (''MT'') of crystalline iodine in Q1 2016 from its five IOsorb® plants. This compares to 127.9MT of crystalline iodine produced from six plants in Q1 2015 of which over 5.5MT was produced at the now closed IOsorb® IO#1 plant. The net iodine production in Q1 from the Company's Oklahoma operations increased year on year. The Board reaffirms its production target of 250-270MT of crystalline iodine in H1 2016.

 

Historically, Iofina's iodine production during the winter months is generally more challenging due to downtime driven by temperature and weather related issues. Additionally, and since the Company's 18 January 2016 RNS, the Oklahoma Corporation Commission (''OCC'') has implemented additional plans to reduce produced brine volumes injected into the Arbuckle geologic formation in response to seismic activity in an approximately 10000 sq. mile area of North West and central Oklahoma.

 

The Board is pleased to report that Iofina and its partners have been working cooperatively to ensure that the Company's IOsorb® plants, at a minimum, maintain current levels of brine processing and ideally expand volumes to some of our plants. These plans can vary per IOsorb® plant, but generally entail being less associated with a particular Salt Water Disposal injection well (''SWD''), and more so being tied into the producer's main brine pipeline network. The tie in work is anticipated to commence shortly at two of the Company's IOsorb® plants and should require minimal capital expenditure. Even with the OCC restrictions and a slowdown of new well drilling rates in Iofina's core area, there remains an abundance of brine for the Company's current plants and potential future sites. The Company has continued to implement strategies to trim iodine production costs.

 

In Q1 2016, iodine pricing for large volume users of iodine slipped below US$25/kg. Whilst not definitive, the Board has seen recent signs of price stabilisation across the global iodine market. Some indicators to this price indication are supply/demand equilibrium for iodine in conjunction with the recent weakening of the US Dollar versus the Japanese Yen and Chilean Peso. The Company sees less downside risk for iodine prices in the near term.

 

During Q1, Iofina had a hearing with respect to the Company's requested judicial review of the Atlantis Water Solution's water permit. The Company expects to receive a ruling late in Q2 of 2016 for this non-core project.

 

 

 

 

 

 

Commenting, President and CEO Dr. Tom Becker, stated: 

 

"I am pleased by our response to the challenges faced in 2016. Iofina produced more iodine from its Oklahoma operations at a significantly lower cost than the same period in 2015 and is on target to reach H1 production goals. 

 

"The actions the Board is taking, in conjunction with the Company's producing partners, to mitigate future risk and ensure brine supply remain encouraging. We have been pleased with the continued sales of produced iodine to the global market. The Board continues to actively execute its business plan whilst managing the debt position in the current challenging commodities market. " 

 

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWFASFMSELL
Date   Source Headline
31st Oct 20137:00 amRNSCommissioning of IO#3 iodine extraction plant
9th Oct 20137:00 amRNSOperational Update
2nd Oct 20132:40 pmRNSHolding(s) in Company
26th Sep 20133:32 pmRNSHolding(s) in Company
25th Sep 20137:00 amRNSHalf Yearly Report
19th Sep 20137:00 amRNSDirectorate Change
6th Sep 20137:00 amRNSNotice of Results
16th Aug 20137:00 amRNSBoard Appointment
2nd Aug 20138:30 amRNSIOSorb Patent Awarded
1st Aug 20137:00 amRNSOperational Update
4th Jul 20138:56 amRNSDirector/PDMR Shareholding
3rd Jul 20135:40 pmRNSChange of Registered Office
28th Jun 20132:05 pmRNSDirector/PDMR Shareholding
25th Jun 20138:15 amRNSProduction & Produced Water Congress 2013
24th Jun 20132:22 pmRNSHolding(s) in Company
24th Jun 201312:00 pmRNSResponse to Share Price Movement
19th Jun 20132:10 pmRNSResult of AGM
19th Jun 20137:00 amRNSAGM Statement
17th Jun 20135:01 pmRNSHolding(s) in Company
12th Jun 201310:08 amRNSBoard Changes
5th Jun 20137:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20137:00 amRNSCompletion of US$15m Convertible Bond Issue
8th May 20137:00 amRNSSuccessful Arrangement of US$15m Convertible Bond
7th May 20137:00 amRNSFinal Results
2nd May 20137:00 amRNSChange in Reporting Currency
29th Apr 20137:47 amRNSNotice of Final Results
29th Apr 20137:00 amRNSAtlantis Water Project Update
17th Apr 20137:00 amRNSHolding(s) in Company
15th Apr 20137:00 amRNSBoard Update
3rd Apr 20135:30 pmRNSHolding(s) in Company
28th Mar 20137:55 amRNSAtlantis Water Project
27th Mar 20134:09 pmRNSHolding(s) in Company
11th Mar 20135:19 pmRNSHolding(s) in Company
7th Mar 20137:00 amRNSOperational Update
11th Feb 20131:34 pmRNSHolding(s) in Company
16th Jan 20137:00 amRNSHolding(s) in Company
14th Jan 20137:00 amRNSAppointment of Non-Executive Director
11th Jan 20137:00 amRNSCommissioning of IO#2 IOsorbT Plant
20th Dec 20128:12 amRNSHolding(s) in Company
18th Dec 20129:00 amRNSHolding(s) in Company
4th Dec 20127:00 amRNSProduction Update
17th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSNotice of Results
16th Aug 20127:00 amRNSCommissioning of Plant
31st Jul 20127:00 amRNSCompletion of Construction of IO#1 IOsorb Plant
20th Jun 20122:25 pmRNSResult of AGM
20th Jun 20127:00 amRNSPurchase of Iodine Extraction Facility
7th Jun 20127:00 amRNSHolding(s) in Company
25th May 20127:00 amRNSPlacing to raise £4.3 million
25th May 20127:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.